CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −880 | $558.30 | $491K | 52,592 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,480 | $560.19 | $829K | 51,112 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −780 | $561.87 | $438K | 50,332 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,480 | $563.09 | $833K | 48,852 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −400 | $566.41 | $227K | 48,452 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −720 | $567.76 | $409K | 47,732 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −739 | $569.15 | $421K | 46,993 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −838 | $570.90 | $478K | 46,155 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −823 | $572.25 | $471K | 45,332 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −160 | $573.15 | $92K | 45,172 |
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 39,240 | ||
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $547.29 | $219K | 325,963 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $548.25 | $154K | 325,683 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $549.40 | $132K | 325,443 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $550.47 | $220K | 325,043 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $551.50 | $88K | 324,883 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $552.63 | $66K | 324,763 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −113 | $553.78 | $63K | 324,650 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −207 | $554.70 | $115K | 324,443 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
Page 28 of 121 · 2,404 trades